Rotator-cuff / subacromial pain: mixed or unspecified subtype · Review · 2026
Does adding shockwave after hyaluronic acid injections help shoulder pain?
In one study in this review, people who had focused shockwave straight after hyaluronic acid shoulder injections had better shoulder function at 3 and 6 months than with injections alone. Pain improved in all groups with no clear difference, and by 12 months function no longer clearly differed.
Possible early help with shoulder function- people in the shockwave study
- 93
- focused shockwave sessions
- 1–2
- months of follow-up
- 12
Good to know: Based on one study of 93 people; one or two shockwave sessions made no clear difference.
Lavigne A, Sandouk E, Hiett A, et al. Shoulder & Elbow, 2026 · Read the paper ↗
How this study worked
What the trials used
- Focused ESWT after HA
- Ko et al. compared three weekly landmark-guided subacromial low-molecular-weight HA injections alone with the same three injections followed immediately by one or two focused ESWT sessions. The review does not report ESWT energy, shock count or session interval.
Who took part
93 people with rotator-cuff tendon pain in one study, within a review of 11 hyaluronic acid studies.
Side effects
No one in the shockwave study reported side effects.
All the numbers and the full appraisal
What the full paper reports.
Narrative review of 11 clinical studies (nine RCTs, two prospective nonrandomized studies) of hyaluronic acid for rotator-cuff tendinopathy. The Ko et al. study enrolled 93 total participants (Table 1 reports “93 (93 HA)”); its three groups were HA alone, HA followed by one focused ESWT session, and HA followed by two sessions. Arm-specific denominators are not stated.
Pain and functional outcomes; numerical scales not reproduced1 reported outcome
Pain and function with HA plus focused ESWT
Pain and functional outcomes; numerical scales not reproduced No numerical between-group estimate
All groups improved from baseline through 12 months. Pain improvement did not differ significantly among groups. Function favored both HA+F-ESWT groups over HA alone at 3 and 6 months, but not significantly at 12 months. One versus two F-ESWT sessions did not differ for pain or function.
Analysis details and source
Table 1 reports total study sample N=93 (“93 (93 HA)”), but arm-specific denominators, scale scores, variance and numerical effect estimates are not reported. No participant reported an adverse event.
How treatment was delivered
Ko et al. compared three weekly landmark-guided subacromial low-molecular-weight HA injections alone with the same three injections followed immediately by one or two focused ESWT sessions. The review does not report ESWT energy, shock count or session interval.
The review says no participant in the Ko study reported an adverse event; no group denominators or broader ESWT safety analysis are provided.
Narrative review, not pooled ESWT analysis. The combination result comes from one study without reproduced group sizes or numerical estimates. No ESWT-only arm was reported, so its effect cannot be separated from HA. Protocol details are incomplete.
Findings checked against the full source by a separate automated reviewer.
Limitations noted by the reviewers
- Narrative review, not pooled ESWT analysis. The combination result comes from one study without reproduced group sizes or numerical estimates. No ESWT-only arm was reported, so its effect cannot be separated from HA. Protocol details are incomplete.
Source-linked critical reading
Scoping / narrative review
Technical source record
Read complete article, its single table, Ko focused ESWT study description, injection characteristics, harms, discussion and conclusion.
One study suggested temporary functional improvement with added focused shockwave, but no pain difference or significant functional advantage remained at one year.
In rotator cuff tendinopathy, what HA injection approaches have been studied and what is known about adding focused ESWT?
Narrative review of studies searched through September 2024, including nine RCTs and two prospective nonrandomized studies.
The review covers rotator cuff tendinopathy; one included study by Ko et al. compared HA with focused ESWT added. Table 1 reports a total of 93 participants in Ko et al. (“93 (93 HA)”). The results describe three groups, but do not state arm-specific denominators; no split of the total is inferred.
Ko et al. compared three weekly landmark-guided subacromial low-molecular-weight HA injections alone with the same injections followed immediately by one or two focused ESWT sessions. Energy and shock count were not stated.
The comparison was HA alone versus HA plus one or two F-ESWT sessions; no ESWT-only arm was described.
The review reports pain and function through 12 months but does not reproduce sample size by arm, scale-specific values or effect estimates.
Pain did not differ significantly among groups. Function favored HA+F-ESWT at months 3 and 6, but not significantly at 12 months. One versus two sessions did not differ.
No participant in the Ko study reported an adverse event; broader safety data are not given.
One combination study, no reproduced numerical estimates and no ESWT-alone arm limit interpretation.
Evidence applies only to focused ESWT after subacromial HA injections and does not establish ESWT monotherapy efficacy.
Trials should include HA-only, ESWT-only and combination arms, report device settings and group-level outcomes, and follow harms and outcomes long term.
Read the original article.
Current evidence on hyaluronic acid injections for rotator cuff tendinopathy: A scoping review.
Lavigne A, Sandouk E, Hiett A, Chang MC, Bélanger V, Lamontagne M, Khadavi M. · Shoulder & elbow · 2026
Open the publication record or available full-text files.
Checked against the full paper · Clinical review: Dr. Marcus Yu Bin Pai, · How we review →